bioAffinity Technologies BIAF
NASDAQ BIAF
$2.20 -0.14 (-5.98%)
At close: Nov 13, 2026 · 4:00 PM EST

bioAffinity Technologies (BIAF) EBITDA Margin (2022 - 2026)

Updated

bioAffinity Technologies (BIAF) reported EBITDA Margin of -321.77% for Q3 2026, down 171.05 percentage points from -150.72% a year earlier and down 105.08 percentage points from the prior quarter.

Analysis

bioAffinity Technologies (BIAF) EBITDA Margin (2022 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, bioAffinity Technologies' EBITDA Margin came in at -239.50%, down 94.19 percentage points year-over-year; for FY2025, it came in at -163.38%, down 74.22 percentage points from FY2024.

  • EBITDA Margin has a three-year change of +83136.14 percentage points (FY2022 to FY2025).
  • By year, EBITDA Margin came in at -89.17% in FY2024 (+215.81 pp), -304.98% in FY2023 (+82994.54 pp) and -83299.52% in FY2022.
  • The Q3 2026 figure ranks as the lowest quarterly EBITDA Margin since Q3 2023.
  • Year over year, EBITDA Margin has now declined in each of the last eight quarters, with an average year-over-year change of -81.84 percentage points over the last eight quarters.
  • The high point for year-over-year EBITDA Margin in five years was Q1 2024 (a gain of 166731.68 percentage points); the low point was Q3 2026 (a drop of 171.05 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -216.69% (Q2 2026), -259.15% (Q1 2026) and -189.18% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn 19.86%
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn -5.84%
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn 15.36%
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn 20.21%
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn -33.96%
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn 4.78%
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn 19.80%
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn -2.44%
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn 18.40%
10 bioAffinity Technologies 1.97 Mn -12.61 Mn -43,896.00 -321.77%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -321.77%
Jun 30, 2026 -216.69%
Mar 31, 2026 -259.15%
Dec 31, 2025 -189.18%
Sep 30, 2025 -150.72%
Jun 30, 2025 -189.24%
Mar 31, 2025 -133.39%
Dec 31, 2024 -126.51%
Sep 30, 2024 -77.54%
Jun 30, 2024 -80.78%
Mar 31, 2024 -74.62%
Dec 31, 2023 -99.11%
Sep 30, 2023 -749.43%
Jun 30, 2023 -8,900.59%
Mar 31, 2023 -166,806.30%
Dec 31, 2022 -68,900.72%
Sep 30, 2022 -84,815.91%
Jun 30, 2022 -52,303.14%
API Access

bioAffinity Technologies EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIAF&period=max&api_key=YOUR_API_KEY